Weiwei Wu
5PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 24, 2026
B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities.Jian Guan, Tiongsun Chia, Bin Li
|Sep 30, 2025
A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPĪ±-Independent Mechanism.Huan Zhang, Fufan He, Lei Cao
|Jul 09, 2021
PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity.Haiping Jiang, Haiqing Ni, Pan Zhang
|Jun 24, 2021
Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody.Haiqing Ni, Lei Cao, Zhihai Wu
|Aug 13, 2019
Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit.Jie Wang, Keke Fei, Hua Jing
Pageof 1
